L-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia.
Goety
C G
CG
Tanner
C M
CM
Cohen
J A
JA
Thelen
J A
JA
Carroll
V S
VS
Klawans
H L
HL
Fariello
R G
RG
D000108:Acetylcarnitine / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002331:Carnitine / Q000031:analogs & derivatives*; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology
D000108:Acetylcarnitine; D002331:Carnitine